Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Operating Income 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2011 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Sonoma Pharmaceuticals Inc. operating income for the quarter ending December 31, 2025 was -678000, a 34.24% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. operating income for the twelve months ending December 31, 2025 was -3.1 M, a 22.92% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. annual operating income for 2025 was -3.7 M, a 21.08% decrease from 2024.
- Sonoma Pharmaceuticals Inc. annual operating income for 2024 was -4.7 M, a 2.87% increase from 2023.
- Sonoma Pharmaceuticals Inc. annual operating income for 2023 was -4.6 M, a 22.37% decrease from 2022.
- Sonoma Pharmaceuticals Inc. annual operating income for 2022 was -5.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sonoma Pharmaceuticals Inc. Operating Income — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Sonoma Pharmaceuticals Inc.'s operating income?
Sonoma Pharmaceuticals Inc. (SNOA) reported operating income of -$4M for fiscal 2025.
Where can I see SNOA's operating income history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.